Author:
Rajkumar Lakshmanaswamy,Kittrell Frances S,Guzman Raphael C,Brown Powel H,Nandi Satyabrata,Medina Daniel
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Beaston GL: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet. 1896, ii: 104-107.
2. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists' Group: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005, 365: 60-62. 10.1016/S0140-6736(05)74803-0.
3. Willett WC, Rockhill B, Hawkinson SE, Hunter D, Colditz GA: Nongenetic factors in the causation of breast cancer. Diseases of the Breast. Edited by: Harris JA, Lippman ME, Morrow M, Osborne CK. 2004, Philadelphia: Lippincott, Williams & Wilkins, 223-276. 3
4. Huggins C, Moon RC, Morii S: Extinction of experimental mammary cancer. I. Estradiol-17β and progesterone. Proc Natl Acad Sci USA. 1962, 48: 379-386. 10.1073/pnas.48.3.379.
5. Sivaraman L, Medina D: Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia. 2002, 7: 77-92. 10.1023/A:1015774524076.